Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil effectively treats mild-moderate male hair loss, alone or combined with other therapies.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Careful planning and technique in upper facial rejuvenation can minimize risks like hair loss, nerve damage, and scarring.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Finasteride reduces hair growth and is safe for women with excessive hair.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Consider benefits and risks of new alopecia treatments for safety.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

The document concludes that more research is needed to create suitable diagnostic criteria and understand PCOS in Korean women, and genetics may allow for personalized treatment.

PRP shows promise for treating female hair loss but needs more research.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Diabetic patients often have ingrown nails due to obesity, high blood pressure, past injuries, bad nail trimming, nail fungus, weak foot pulse, and weak knee reflex.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

Healthcare providers should start with simple fertility tests and treatments before referring patients to specialists.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Treat hirsutism in premenopausal women with oral contraceptives and consider additional treatments if needed.

Androgenetic alopecia is linked to a higher risk of coronary heart disease due to certain genetic factors and high homocysteine levels.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Hair restoration surgery can worsen psoriasis, so careful planning is needed.

Female pattern baldness may indicate a higher risk of coronary artery disease.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.